Sangamo Biosciences, Inc. (NASDAQ:SGMO)

CAPS Rating: 3 out of 5

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.


Player Avatar pchop123 (80.25) Submitted: 9/29/2011 12:08:20 PM : Outperform Start Price: $4.56 SGMO Score: -29.05

great price to buy in at & be patient for the incubation period to reap great benefit

Featured Broker Partners